Asia Pacific Surgical Robots Market Outlook to 2028

Asia Pacific Surgical Robots Market Overview

The Asia Pacific Surgical Robots Market was valued at USD 1.98 Billion in 2023. This growth can be attributed to the increasing adoption of surgical robots in hospitals and healthcare facilities, driven by their ability to enhance precision, reduce recovery times, and improve patient outcomes.

The market is dominated by several key players, including Intuitive Surgical, Medtronic, Stryker Corporation, Smith & Nephew, and Johnson & Johnson. These companies are leading the market with their innovative robotic surgery systems, extensive research and development activities, and strategic partnerships with healthcare institutions.

Medtronic's Hugo robotic-assisted surgery system has gained regulatory approval in Japan, marking its entry into the world's third-largest robotics market. This expansion, along with approvals in the EU and Canada, aims to enhance access to minimally invasive surgeries, addressing over 80% of global RAS procedures in general surgery, urology, and gynecology.

Japan is currently the leading market for surgical robots in the Asia Pacific region, due to Japans advanced healthcare infrastructure, high adoption rate of new technologies, and strong government support for medical innovation. The country's rapidly aging population has also driven the demand for minimally invasive surgeries, further boosting the market for surgical robots.

Asia Pacific Surgical Robots Market Segmentation

The market is segmented into various factors like product, application, and region.

By Product: The market is segmented by product into robotic systems, instruments & accessories, and services. In 2023, robotic systems held a dominant market share, due to the high initial cost of these systems and their critical role in enabling robotic-assisted surgeries.

By Application: The market is segmented by application into general surgery, gynecological surgery, urological surgery, orthopedic surgery, and others. In 2023, general surgery emerged as the leading segment, due to the widespread use of robotic systems in complex procedures, such as colorectal and gastrointestinal surgeries, which has fueled the growth of this segment.

By Region: The market is segmented by region into China, South Korea, Japan, India, Australia, and the Rest of APAC. In 2023, Japan led the market with its advanced healthcare system, strong government support for innovation, and a large geriatric population in need of surgical care.

Asia Pacific Surgical Robots Market Competitive Landscape

Company Name

Establishment Year

Headquarters

Intuitive Surgical

1995

Sunnyvale, California, USA

Medtronic

1949

Dublin, Ireland

Stryker Corporation

1941

Kalamazoo, Michigan, USA

Smith & Nephew

1856

London, United Kingdom

Johnson & Johnson

1886

New Brunswick, New Jersey, USA

Johnson & Johnson: Johnson & Johnson (J&J) has acquired Auris Health for $3.4 billion, marking the largest robotics and medtech private M&A deal in history. The deal includes up to $2.35 billion in milestone payments, totaling approximately $5.75 billion. Auris's Monarch platform aims to improve early lung cancer diagnosis and treatment access.

Intuitive Surgical: Intuitive Surgical's new da Vinci 5 robotic surgery system saw a faster-than-expected rollout in Q2 2024, with 70 units placed, making up 47% of U.S. placements. This contributed to a 14.5% increase in revenue to $2.01 billion and a 25.2% increase in net income to $526.9 million compared to the same period last year.

Asia Pacific Surgical Robots Market Analysis

Market Growth Drivers

Increased Surgical Procedures in Aging Population: The Asia Pacific region, particularly Japan and South Korea, is experiencing a rapid increase in the aging population. By 2024, Japan alone will have over 36 million people aged 65 and older. This demographic shift is leading to a surge in the number of surgical procedures required for age-related conditions. As a result, the demand for surgical robots, which enhance precision and reduce recovery times, is expected to rise.

Healthcare Infrastructure Development: The Indian government's commitment to healthcare infrastructure is evident in its allocation of over $200 billion for medical infrastructure by 2024. This investment is set to significantly boost the adoption of advanced medical technologies, including surgical robots, across India, enhancing healthcare accessibility and driving market growth in the surgical robots sector.

Surge in Chronic Diseases: The rising prevalence of chronic diseases, such as cardiovascular diseases and cancer, is a significant growth driver for the surgical robots market in the Asia Pacific region. In 2024, it is estimated that over 8 million new cases of cancer will be diagnosed in the region, necessitating complex surgical interventions. Surgical robots, known for their precision, are increasingly being utilized in oncology surgeries.

Market Challenges

High Cost of Surgical Robots: One of the primary challenges facing the surgical robots market in the Asia Pacific region is the high cost associated with the purchase, installation, and maintenance of these systems. The average cost of a surgical robot in 2024 is high, which is prohibitively expensive for many smaller hospitals, particularly in developing countries like India and Vietnam.

Shortage of Skilled Surgeons: The effective use of surgical robots requires highly trained surgeons, and there is a significant shortage of such professionals in the Asia Pacific region. In 2024, it was reported that less than 20% of surgeons in India and Southeast Asia had received formal training in robotic-assisted surgery.

Government Initiatives

Chinas Healthcare Modernization Plan: In 2024, China aims to enhance public healthcare access and reduce financial burdens through comprehensive reforms. Key initiatives include improving primary healthcare services, reforming public hospital payment systems, and expanding drug procurement programs to cover 500 medications, ensuring better healthcare for all citizens.

Indias Subsidy Scheme for Robotic Surgeries: The Indian government introduced a subsidy scheme in 2024 to promote the use of surgical robots in public hospitals. The scheme provides financial assistance of up to 20% of the cost of robotic surgery systems, making it easier for hospitals, particularly in rural areas, to adopt this technology.

Asia Pacific Surgical Robots Market Future Outlook

The Asia Pacific surgical robots industry is expected to grow significantly, with advancements in AI integration, expansion into emerging markets, development of cost-effective systems, and increased government support driving growth over the next five years.

Future Market trends

Increased Adoption of AI in Surgical Robots: Over the next five years, the Asia Pacific surgical robots industry is expected to see a significant increase in the integration of artificial intelligence (AI) into robotic systems. AI will enhance the precision and efficiency of robotic-assisted surgeries, allowing for more complex procedures to be performed with greater accuracy.

Development of Cost-Effective Robotic Systems: In response to the high costs associated with current surgical robots, the next five years will see the development and introduction of more cost-effective robotic systems in the Asia Pacific region. These new systems will be designed to be affordable for mid-sized hospitals and emerging markets, without compromising on quality or precision.
Please Note: It will take 5-7 business days to complete the report upon order confirmation